Share-based Payment Arrangement, Expense of Medicus Pharma Ltd. from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Medicus Pharma Ltd. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2023 to 30 Sep 2025.
  • Medicus Pharma Ltd. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $852,757.
  • Medicus Pharma Ltd. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $1,174,206.
  • Medicus Pharma Ltd. annual Share-based Payment Arrangement, Expense for 2024 was $713,119, a 623% increase from 2023.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Medicus Pharma Ltd. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,174,206 $852,757 +$852,757 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $321,449 $117,448 -$467,994 -80% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $789,443 $112,277 +$76,324 +212% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $713,119 $91,724 01 Oct 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
Q3 2024 $0 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 $585,442 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q1 2024 $35,953 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1

Medicus Pharma Ltd. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $713,119 +$614,534 +623% 01 Jan 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
2023 $98,585 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.